Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Report
|
SuperGen/MGI Pharma's Dacogen and Celgene's Revlimid are in pre-registration for treatment of myelodysplastic syndrome (MDS). However, a significant proportion of the MDS population will be left underserved by pharmacotherapy.
Published By Datamonitor
|
18 Oct 2005 |
$1900
|
Report
|
Overview of vaccine antigen delivery technologies with detailed profiles and critical assessment of key approaches. Discussion of opportunities and challenges for the sector and outlook for the next decade.
Published By Datamonitor
|
19 May 2009 |
$3800
|
Report
|
Provides analysis of key events and their impact on the fibromyalgia market over the last year (July 2008June 2009). Includes indication- and country-specific 10-year forecasts of key marketed, generic, and pipeline products to 2018.
Published By Datamonitor
|
03 Jun 2009 |
$15200
|
Report
|
Provides analysis of key events and their impact on the ADHD market since 2008. Includes an event-based and country-specific 10 year forecast of key marketed, generic, and pipeline products to 2018 in the seven major markets.
Published By Datamonitor
|
03 Jul 2009 |
$15200
|
Report
|
This report gives a comprehensive overview of trends in epidemiology, diagnosis, treatment and referral patterns for skin and soft tissue infections (SSTIs). It discusses the challenges, opportunities and future developments for the SSTI drug market.
Published By Datamonitor
|
16 Jul 2009 |
$3800
|
Report
|
Overview of the current prostate cancer clinical pipeline, including in-depth analysis of late-phase products, clinical trial data, sales forecasts through to 2018, Datamonitor drug assessment summaries and key opinion leader insight.
Published By Datamonitor
|
14 Aug 2009 |
$11400
|
Report
|
Full analysis of the current and future hormonal contraceptives drug market, with country-specific forecasts to 2018 of marketed, generic, and key pipeline drugs in the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK).
Published By Datamonitor
|
02 Oct 2009 |
$15200
|
Report
|
Analysis of the current and future antidepressant drug class market. Includes sales forecasts to 2018 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK) of key marketed brands, generics, and pipeline products.
Published By Datamonitor
|
08 Oct 2009 |
$15200
|
Report
|
Analysis of the future potential of anticonvulsants market. Includes sales forecasts over 2009-2018 across the seven major markets (US, Japan, France, Germany, Italy, Spain, and the UK) of key marketed brands, generics, and pipeline agents.
Published By Datamonitor
|
08 Oct 2009 |
$15200
|
Report
|
Primary research-based analysis of the chronic leukemias market. Includes patient segmentation, treatment trends, prescribing influences and brand perception.
Published By Datamonitor
|
08 Oct 2009 |
$15200
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.